JP2015521206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521206A5 JP2015521206A5 JP2015515530A JP2015515530A JP2015521206A5 JP 2015521206 A5 JP2015521206 A5 JP 2015521206A5 JP 2015515530 A JP2015515530 A JP 2015515530A JP 2015515530 A JP2015515530 A JP 2015515530A JP 2015521206 A5 JP2015521206 A5 JP 2015521206A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- isolated
- har
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 23
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 239000004471 Glycine Substances 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000000539 dimer Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000568 immunological adjuvant Substances 0.000 claims 1
- 239000012678 infectious agent Substances 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261656256P | 2012-06-06 | 2012-06-06 | |
| US61/656,256 | 2012-06-06 | ||
| PCT/EP2013/061751 WO2013182661A1 (en) | 2012-06-06 | 2013-06-06 | Peptides derived from viral proteins for use as immunogens and dosage reactants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015521206A JP2015521206A (ja) | 2015-07-27 |
| JP2015521206A5 true JP2015521206A5 (enExample) | 2016-08-12 |
| JP6310909B2 JP6310909B2 (ja) | 2018-04-11 |
Family
ID=48577073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015515530A Expired - Fee Related JP6310909B2 (ja) | 2012-06-06 | 2013-06-06 | 免疫原及び投薬反応物として使用するためのウイルスタンパク質に由来するペプチド |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10501499B2 (enExample) |
| EP (1) | EP2859011B1 (enExample) |
| JP (1) | JP6310909B2 (enExample) |
| KR (1) | KR20150018870A (enExample) |
| CN (1) | CN104619718A (enExample) |
| AU (1) | AU2013273482A1 (enExample) |
| BR (1) | BR112014030466A2 (enExample) |
| CA (1) | CA2874923C (enExample) |
| EA (1) | EA201492262A1 (enExample) |
| HK (1) | HK1207871A1 (enExample) |
| IL (1) | IL235891A0 (enExample) |
| IN (1) | IN2014KN02769A (enExample) |
| MX (1) | MX2014014683A (enExample) |
| NZ (1) | NZ702146A (enExample) |
| WO (1) | WO2013182661A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10342846B2 (en) * | 2013-02-04 | 2019-07-09 | University Of Notre Dame Du Lac | Nanoparticle drug delivery systems |
| US10988531B2 (en) | 2014-09-03 | 2021-04-27 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| AU2017281389B2 (en) * | 2016-06-20 | 2024-02-22 | Isa Pharmaceuticals B.V. | Formulation of a peptide vaccine |
| CN110290805A (zh) * | 2017-01-03 | 2019-09-27 | 埃默杰克斯疫苗控股有限公司 | 通用流感疫苗组合物 |
| CN110548136A (zh) * | 2018-05-30 | 2019-12-10 | 王美亮 | 汉坦病毒长肽疫苗 |
| US11203614B2 (en) * | 2019-03-25 | 2021-12-21 | Immunwork Inc. | Composite polypeptide having a metal binding motif and molecular construct comprising the same |
| KR102393872B1 (ko) * | 2019-08-28 | 2022-05-04 | 엠브릭스 주식회사 | 바이러스 외피를 손상시키는 m2 단백질 유래 항바이러스 펩타이드 및 그의 용도 |
| US20230109142A1 (en) * | 2020-02-14 | 2023-04-06 | Immunor As | Corona virus vaccine |
| KR102707584B1 (ko) * | 2020-04-02 | 2024-09-19 | 조선대학교산학협력단 | 코로나바이러스 감염증１９의 진단 및 백신을 위한 재조합 뉴클레오캡시드 단백질 및 이의 용도 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| JPS5896026A (ja) | 1981-10-30 | 1983-06-07 | Nippon Chemiphar Co Ltd | 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤 |
| US4609546A (en) | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4606918A (en) | 1983-08-22 | 1986-08-19 | Syntex (U.S.A.) Inc. | Polyoxypropylene-polyoxyethylene block polymer based adjuvants |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4766106A (en) | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
| CA1294215C (en) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| CA1292686C (en) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| DK0596032T4 (da) | 1991-07-25 | 2004-07-26 | Idec Pharma Corp | Induktion af cytotoksiske T-lymfocytsvar |
| MA22842A1 (fr) | 1992-03-27 | 1993-10-01 | Smithkline Beecham Biolog | Procede de preparation de compositions de vaccin. |
| JP3626996B2 (ja) | 1992-05-23 | 2005-03-09 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン |
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| EP0689454B2 (en) | 1993-03-23 | 2005-02-23 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
| PT735893E (pt) | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
| CA2175692A1 (en) | 1993-11-04 | 1995-05-11 | Geert Leroux-Roels | Immunodominant human t-cell epitopes of hepatitis c virus |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US5709995A (en) | 1994-03-17 | 1998-01-20 | The Scripps Research Institute | Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| EP0754193B1 (en) | 1994-04-08 | 2000-06-14 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES | Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| BR9708220A (pt) | 1996-03-21 | 2000-01-04 | Epimmune Inc | Peptìdios de ligação hla-a2.1 e seus usos |
| JP3945822B2 (ja) | 1996-05-24 | 2007-07-18 | カイロン コーポレイション | 複数エピトープ融合タンパク質 |
| US6566330B1 (en) | 1996-10-22 | 2003-05-20 | Medical University Of South Carolina Foundation Research Development | Positively charged non-natural amino acids, methods of making and using thereof in peptides |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| KR100731820B1 (ko) | 1998-10-05 | 2007-06-25 | 파멕사 에이/에스 | 치료적 백신화를 위한 새로운 방법 |
| NO311807B1 (no) * | 1999-03-04 | 2002-01-28 | Bionor Immuno As | HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV |
| CA2377525A1 (en) | 1999-07-19 | 2001-03-29 | Epimmune Inc. | Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions |
| US20020076415A1 (en) | 1999-12-14 | 2002-06-20 | Jing-Hsiung Ou | Hepatitis C virus gene products |
| GB0005703D0 (en) | 2000-03-09 | 2000-05-03 | Alpharma As | Compounds |
| JP2004522415A (ja) | 2000-09-01 | 2004-07-29 | エピミューン インコーポレーティッド | Ｈｌａ結合ペプチドおよびその使用方法 |
| NO314588B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV |
| NO314587B1 (no) * | 2000-09-04 | 2003-04-14 | Bionor Immuno As | HIV regulatoriske- og hjelpepeptider, antigener, vaksinepreparater, immunoassay testsett og en metode for påvisning av antistoffer fremkaltav HIV |
| EP1195381A1 (de) | 2000-09-28 | 2002-04-10 | Immusystems GmbH | CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope |
| GB0026094D0 (en) | 2000-10-25 | 2000-12-13 | Imp College Innovations Ltd | Methods |
| US20050276812A1 (en) | 2004-06-01 | 2005-12-15 | Genentech, Inc. | Antibody-drug conjugates and methods |
| US7702465B2 (en) | 2002-06-10 | 2010-04-20 | Algonomics N.V. | Method, computing routine, device for predicting properties of MHC/peptide complexes, and data and peptides produced therefrom |
| KR101240547B1 (ko) * | 2002-08-12 | 2013-03-08 | 더 카운실 오브 더 퀸스랜드 인스티튜트 오브 메디칼 리서어치 | Ｔ-헬퍼 및 ｂ-세포 에피토프를 포함하는 신규한 면역원성리포펩타이드 |
| WO2004024182A2 (en) | 2002-09-13 | 2004-03-25 | Intercell Ag | Method for isolating hepatitis c virus peptides |
| EP1652858A1 (en) | 2004-10-28 | 2006-05-03 | Innogenetics N.V. | Peptides for inducing a CTL and/or HTL response to hepatitis C virus |
| WO2006065533A2 (en) | 2004-11-29 | 2006-06-22 | Seattle Genetics, Inc. | Engineered antibodies and immunoconjugates |
| US8252893B2 (en) | 2005-01-31 | 2012-08-28 | Board Of Trustees Of The University Of Arkansas | CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
| WO2008107400A1 (en) * | 2007-03-02 | 2008-09-12 | Genimmune N.V. | Hcv polyepitope construct and uses thereof |
| EP2448593B1 (en) | 2009-07-03 | 2020-11-25 | Bionor Immuno AS | Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means |
| JP6069212B2 (ja) * | 2010-12-02 | 2017-02-01 | ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ | ペプチド骨格設計 |
| JP6294076B2 (ja) | 2011-01-06 | 2018-03-14 | ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ | 多量体ペプチド |
| US8618303B2 (en) * | 2011-01-07 | 2013-12-31 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives |
-
2013
- 2013-06-06 KR KR20157000273A patent/KR20150018870A/ko not_active Withdrawn
- 2013-06-06 CN CN201380039292.3A patent/CN104619718A/zh active Pending
- 2013-06-06 NZ NZ702146A patent/NZ702146A/en not_active IP Right Cessation
- 2013-06-06 HK HK15108544.7A patent/HK1207871A1/xx unknown
- 2013-06-06 EA EA201492262A patent/EA201492262A1/ru unknown
- 2013-06-06 CA CA2874923A patent/CA2874923C/en active Active
- 2013-06-06 IN IN2769KON2014 patent/IN2014KN02769A/en unknown
- 2013-06-06 US US14/406,016 patent/US10501499B2/en active Active
- 2013-06-06 WO PCT/EP2013/061751 patent/WO2013182661A1/en not_active Ceased
- 2013-06-06 BR BR112014030466A patent/BR112014030466A2/pt not_active IP Right Cessation
- 2013-06-06 JP JP2015515530A patent/JP6310909B2/ja not_active Expired - Fee Related
- 2013-06-06 MX MX2014014683A patent/MX2014014683A/es unknown
- 2013-06-06 AU AU2013273482A patent/AU2013273482A1/en not_active Abandoned
- 2013-06-06 EP EP13727202.7A patent/EP2859011B1/en active Active
-
2014
- 2014-11-25 IL IL235891A patent/IL235891A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521206A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| ES2691091T3 (es) | Vacuna conjugada de péptido antigénico de WT1 | |
| JP2016538885A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| JP2014501510A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| JP2018509935A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| JP2014530010A5 (enExample) | ||
| JP2014509838A5 (enExample) | ||
| JP2014507144A5 (ja) | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 | |
| JP2016534034A5 (enExample) | ||
| JP2016503655A5 (enExample) | ||
| JP2013517783A5 (enExample) | ||
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2015212284A5 (enExample) | ||
| JP2015533791A5 (enExample) | ||
| FI3564378T3 (fi) | Immunogeeninen koostumus | |
| JP2017523985A5 (enExample) | ||
| JP2015164424A5 (enExample) | ||
| JP2016514713A5 (enExample) | ||
| JP2008530975A5 (enExample) | ||
| JP2012529293A5 (enExample) |